Does Remdesivir Cause Anemia?
Remdesivir is an antiviral drug that has been approved by the U.S. Food and Drug Administration (FDA) to treat adults and children with COVID-19. It is given intravenously, either as an injection or as an infusion. While there have been many studies on the efficacy of Remdesivir in treating COVID-19, there has been limited research into the possible side effects of the drug.
Anemia is a condition in which there is a decrease in the number of red blood cells or hemoglobin in the blood, leading to decreased oxygen-carrying capacity. Symptoms of anemia can include fatigue, pale skin, and shortness of breath.
There have been no reports of anemia associated with the use of Remdesivir in clinical trials or postmarketing surveillance. However, as with any medication, there is a potential for adverse reactions to occur. Therefore, it is important to discuss any potential side effects with your healthcare provider prior to taking Remdesivir.
